Cargando…
Adjunct N-Acetylcysteine Treatment in Hospitalized Patients With HIV-Associated Tuberculosis Dampens the Oxidative Stress in Peripheral Blood: Results From the RIPENACTB Study Trial
Tuberculosis (TB) still causes significant morbidity and mortality worldwide, especially in persons living with human immunodeficiency virus (HIV). This disease is hallmarked by persistent oxidative stress and systemic inflammation. N-acetylcysteine (NAC), a glutathione (GSH) precursor, has been sho...
Autores principales: | Safe, Izabella P., Amaral, Eduardo P., Araújo-Pereira, Mariana, Lacerda, Marcus V. G., Printes, Vitoria S., Souza, Alexandra B., Beraldi-Magalhães, Francisco, Monteiro, Wuelton M., Sampaio, Vanderson S., Barreto-Duarte, Beatriz, Andrade, Alice M. S., Spener-Gomes, Renata, Costa, Allyson Guimarães, Cordeiro-Santos, Marcelo, Andrade, Bruno B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889506/ https://www.ncbi.nlm.nih.gov/pubmed/33613521 http://dx.doi.org/10.3389/fimmu.2020.602589 |
Ejemplares similares
-
Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis: An open-label, randomized, phase II trial (RIPENACTB Study)
por: Safe, Izabella Picinin, et al.
Publicado: (2020) -
Examination of respiratory specimens improves microbiological diagnosis of patients with presumptive extrapulmonary tuberculosis
por: Spener-Gomes, Renata, et al.
Publicado: (2021) -
N-acetylcysteine as an adjunct treatment of schizophrenia
por: Freitas, R. Mota, et al.
Publicado: (2021) -
Plasmodium vivax malaria elimination: should innovative ideas from
the past be revisited?
por: Val, Fernando Fonseca, et al.
Publicado: (2014) -
N-acetylcysteine as an adjunctive treatment for smoking cessation: a randomized clinical trial
por: Machado, Regina C.B.R., et al.
Publicado: (2020)